Elyssa Lopez · · 5 min readDoctor Anywhere pieces together a profit
Welcome to Tech in Asia’s daily newsletter, your essential dose of Asia’s tech and startup buzz. Not yet a subscriber? Register here. Got a story tip? Send it to editors@techinasia.com.
In focus
- Doctor Anywhere posts a positive operating profit for the first time in four years
- How hyperscalers continue to grow despite lack of data on AI traffic
- Meta stages a comeback in the AI race with Muse Glimmer
Hello reader,
The road to recovery is rarely straightforward. You may find yourself recovering from an allergic reaction, only to be hit with the flu right after. Sadly, that’s the story of my life.
For some of the companies we’re diving into today, recovery – whether financial or strategic – has come with its own share of roadblocks.
Take Singapore’s Doctor Anywhere. The telehealth platform ceased operations in Vietnam in 2025 after six years in the country. This appears to have worked in its favor – by the end of that year, Doctor Anywhere had posted its first operating profit.
I wrote about the company’s turnaround in today’s first Top Story.
Meanwhile in Silicon Valley, Meta looks to be cracking its knuckles as it tries to get back into the AI race with the launch of its open-source model, Muse Glimmer. After its Manus acquisition was blocked by the Great Wall of Chinese regulators, Meta is now looking to carve out its own place in the AI boom with a model built for agents.
My colleague Glenn dives into the move in detail in the Spotlight, including how it could prove instrumental in the US’ broader AI race against China.
Both Meta and Doctor Anywhere are still some distance from where they want to be in their respective “races,” but they are finding a path forward.
Elyssa Lopez, journalist
Top Stories
1️⃣ Doctor Anywhere posts healthier operations in 2025
Doctor Anywhere founder Wai Mun Lim / Photo credit: Doctor Anywhere
The telehealth platform recorded US$868,000 in operating profit for the 2025 fiscal year, the first time it hit a positive in four years. Doctor Anywhere is looking to improve its financials further, with cash breakeven targeted for the “near to medium term.”
Spotlight
Trending news
Stay updated on the go with our mobile app.
Get latest insights with smoother, more personalized experience through TIA mobile app.
